Portfolio company
PulseMedica Corp.
Canada · £9.5m raised
Raised
£9.5m
Latest stage
Pre-seed
Rounds recorded
1
Backed by
4 investors
Sectors
About
This company develops an imaging and laser platform to screen and treat vitreoretinal diseases for patients with conditions like eye floaters.
SourceFunding history · 1
Similar companies
PulseSight Therapeutics
This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.
Norlase
This company develops portable ophthalmic laser systems for retinal and glaucoma care, serving ophthalmologists and medical clinics worldwide.
Profundus
This company develops high-resolution adaptive optics retinal imaging cameras and software for medical researchers and clinicians to facilitate early disease detection.
Maculaser
The company develops temperature-controlled laser therapy devices for ophthalmologists to treat retinal disorders such as age-related macular degeneration and diabetic macular oedema.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
Pixium Vision
This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.
ViaLase
This company develops femtosecond laser systems for treating glaucoma, providing non-invasive surgical tools to eye care professionals and healthcare providers.
AI4Eyes Medical Technologies
This company develops artificial intelligence software and imaging hardware for eye care professionals to diagnose and manage ocular diseases.
